Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy
Listen to this summary
The authors aimed to evaluate the population health impact of the 2026 dyslipidemia guideline on eligibility for primary prevention statin therapy among U.S. adults aged 30 to 79 years without known atherosclerotic cardiovascular disease (ASCVD). Their analysis revealed that the new guidelines significantly expanded the eligible population for statin therapy, with an estimated 87.5 million adults now qualifying, including 21.5 million who are newly eligible, primarily consisting of younger and lower-risk individuals compared to those previously recommended for treatment.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from JAMA
View all →Jul 23, 2026 · JAMA
Safe Sleep Video Intervention via Text Messaging to Low-Income Families: The SMARTER Randomized Clinical Trial
Jul 22, 2026 · JAMA
Gastroparesis: A Review
Jul 22, 2026 · JAMA
Mechanical Thrombectomy in Ischemic Stroke With a Medium or Distal Arterial Occlusion: The DISCOUNT Randomized Clinical Trial
Jul 16, 2026 · JAMA
Hip Fractures: A Review
Jul 15, 2026 · JAMA
Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment
Jul 13, 2026 · JAMA
Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Jul 23, 2026 · Lancet (London, England)
Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial
Jul 22, 2026 · Lancet (London, England)
High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial
Jul 22, 2026 · The New England journal of medicine
Antiretroviral Therapy
Jul 22, 2026 · The New England journal of medicine
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
Jul 21, 2026 · Circulation
Association of Pulmonary Vascular Remodeling With Cardiac Structure and Function, Pulmonary Pressure, and Heart Failure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study
Jul 21, 2026 · Circulation
Effects of a "Food Is Medicine" Intervention on Glucose Control Among Medicaid-Insured Patients With Type 2 Diabetes: A Randomized Controlled Trial
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
